J. Silvio Gutkind, Ph.D.

Title(s)Professor, Pharmacology
SchoolHealth Sciences
ORCID ORCID Icon0000-0002-5150-4482 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of Buenos Aires, Buenos Aires, ArgentinaPh.D.1985Pharmacology and Biochemistry
    University of Buenos Aires, Buenos Aires, ArgentinaBiochemistry Degree (M.Sc.)1983Biochemistry
    University of Buenos Aires, Buenos Aires, ArgentinaPharmacy Degree (M.Sc.)1980Pharmacology
    Collapse Awards and Honors
    National Academy of Medicine, USA2019Elected, National Academy of Medicine
    Gordon Conference in Molecular Pharmacology, Ventura CA2019Elected Co-Chair, Gordon Conference in Molecular Pharmacology
    American Society for Pharmacology and Experimental Therapeutics (ASPET)2019Elected Chair, Division of Molecular Pharmacology
    International Association of Dental Research (IADR)2017Outstanding Scientist Award
    Pharmaceutical Research and Manufacturers of America (PhRMA)2015Research & Hope Award for “Excellence in Academic Research”
    Annual Meeting and 5th World Congress-IFHNOS2014Elected, Keynote Lecture, 2014 American Head and Neck Society (AHNS)
    Israel Cancer Research Foundation2012Elliot Osserman Award
    Israel Cancer Research Foundation2005Elliot Osserman Award
    NIH2005NIH Director's Award
    International Association of Dental Research (IADR) 2004Distinguished Scientist Award, Oral Medicine and Pathology
    NIDCR, NIH1997NIDR Director’s Exemplary Service Award
    NIH1996NIH Merit Award

    Collapse Overview 

    Collapse Research 
    Collapse Research Activities and Funding
    Multidisciplinary Educational Approach to Reducing Cancer Disparities
    NIH/NCI R25CA221779Sep 1, 2019 - Aug 31, 2024
    Role: Principal Investigator
    Stimulating Neo-Antigen Specific T Cell Responses in Head and Neck Cancers
    NIH U01DE028227Sep 19, 2018 - Aug 31, 2023
    Role: Principal Investigator, MPI
    Targeting the EGFR-PI3K/mTOR Signaling Circuitry: A Network-Based Approach for Oral Cancer Precision Therapy
    NIH R01DE026870Aug 1, 2018 - Jul 31, 2023
    Role: Principal Investigator
    Area C: Genome-wide identification and targeting of resistance to cancer therapy
    NIH R33CA225291Sep 30, 2017 - Aug 31, 2020
    Role: Principal Investigator
    Targeting Signaling Vulnerabilities for Oral Cancer Prevention
    NIH/NIDCR R01DE026644Jan 1, 2017 - Dec 31, 2021
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Websites
    Collapse Faculty Mentoring
    Collapse Twitter